Track market-moving stories before they get noisy

SANTA ANA, Calif.--(BUSINESS WIRE)--First American Data & Analytics, a leading national provider of property-centric information, risk management and valuation solutions and a division of First American Financial Corporation (NYSE: FAF), today released its September 2026 Home Price Index (HPI) report, finding U.S. home prices nationally increased 1.2 percent year over year. The report tracks home price changes less than four weeks behind real time at the national, state and metropolitan (Co.

Kinder Morgan (KMI - Free Report) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

Over the past month, shares of this oil and natural gas pipeline and storage company have returned +12%, compared to the Zacks S&P 500 composite's -1.2% change. During this period, the Zacks Oil and Gas - Production and Pipelines industry, which Kinder Morgan falls in, has gained 1.7%. The key question now is: What could be the stock's future direction?

While media releases or rumors about a substantial change in a company's business prospects usually make its stock 'trending' and lead to an immediate price change, there are always some fundamental facts that eventually dominate the buy-and-hold decision-making.

Earnings Estimate RevisionsRather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection. This is because we believe the fair value for its stock is determined by the present value of its future stream of earnings.

We essentially look at how sell-side analysts covering the stock are revising their earnings estimates to reflect the impact of the latest business trends. And if earnings estimates go up for a company, the fair value for its stock goes up. A higher fair value than the current market price drives investors' interest in buying the stock, leading to its price moving higher. This is why empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.

Kinder Morgan is expected to post earnings of $0.40 per share for the current quarter, representing a year-over-year change of +2.6%. Over the last 30 days, the Zacks Consensus Estimate has changed +1.3%.

For the current fiscal year, the consensus earnings estimate of $1.56 points to a change of +20% from the prior year. Over the last 30 days, this estimate has changed +2.9%.

For the next fiscal year, the consensus earnings estimate of $1.55 indicates a change of -1% from what Kinder Morgan is expected to report a year ago. Over the past month, the estimate has remained unchanged.

Having a strong externally audited track record, our proprietary stock rating tool, the Zacks Rank, offers a more conclusive picture of a stock's price direction in the near term, since it effectively harnesses the power of earnings estimate revisions. Due to the size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, Kinder Morgan is rated Zacks Rank #3 (Hold).

The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:

12 Month EPS

Revenue Growth ForecastWhile earnings growth is arguably the most superior indicator of a company's financial health, nothing happens as such if a business isn't able to grow its revenues. After all, it's nearly impossible for a company to increase its earnings for an extended period without increasing its revenues. So, it's important to know a company's potential revenue growth.

For Kinder Morgan, the consensus sales estimate for the current quarter of $4.62 billion indicates a year-over-year change of +2.5%. For the current and next fiscal years, $18.33 billion and $18.92 billion estimates indicate +8.2% and +3.2% changes, respectively.

Last Reported Results and Surprise HistoryKinder Morgan reported revenues of $4.53 billion in the last reported quarter, representing a year-over-year change of +9.3%. EPS of $0.35 for the same period compares with $0.29 a year ago.

Compared to the Zacks Consensus Estimate of $4.38 billion, the reported revenues represent a surprise of +3.52%. The EPS surprise was +6.06%.

The company beat consensus EPS estimates in each of the trailing four quarters. The company topped consensus revenue estimates each time over this period.

ValuationWithout considering a stock's valuation, no investment decision can be efficient. In predicting a stock's future price performance, it's crucial to determine whether its current price correctly reflects the intrinsic value of the underlying business and the company's growth prospects.

Comparing the current value of a company's valuation multiples, such as its price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), to its own historical values helps ascertain whether its stock is fairly valued, overvalued, or undervalued, whereas comparing the company relative to its peers on these parameters gives a good sense of how reasonable its stock price is.

As part of the Zacks Style Scores system, the Zacks Value Style Score (which evaluates both traditional and unconventional valuation metrics) organizes stocks into five groups ranging from A to F (A is better than B; B is better than C; and so on), making it helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.

Kinder Morgan is graded D on this front, indicating that it is trading at a premium to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.

ConclusionThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Kinder Morgan. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.

On October 26, 2026, we conducted a DCF analysis for Analog Devices Inc (ADI), which has shown impressive price performance over the past year. The stock has in

The company joins the ranks of leading organizations that help businesses grow, scale, and thrive 

Paychex recognized as an essential B2B partner that businesses can depend on to help them succeedRecognition reflects customer-validated excellence across Paychex Flex®, Paycor®, and SurePayroll, demonstrating Paychex's commitment to helping organizations grow, scale, and thrive ROCHESTER, N.Y., Oct. 26, 2026 (GLOBE NEWSWIRE) --  Paychex (Nasdaq: PAYX), a leading provider of expert-enabled HR, payroll, and benefits, today announced it has been named to the 2026 Inc. Power Partners list. The annual list, produced by Inc., the leading media brand and playbook for entrepreneurs and the business leaders shaping the future, honors B2B organizations that have a proven track record of supporting entrepreneurs and helping companies grow.

“Business owners have no shortage of tools at their disposal, and B2B companies need to make clear why their products and services are worth the investment,” says Bonny Ghosh, editorial director at Inc. “The companies on this year’s Power Partners list have done just that. They don’t just have customers – they have superfans and evangelists. Across industries like marketing, financial services, and technology, they’ve proved their dedication to helping fellow business owners grow and succeed.” 

To build a successful business, leaders need experts, tools, and services they can trust. Inc.’s Power Partner Awards present the definitive list of B2B partners in the U.S. and around the globe that small businesses and entrepreneurs can rely on. These companies have established robust reputations in their industries for the positive impact they have had on their clients' businesses.

“It’s an honor to be named one of Inc.’s 2026 Power Partners. What makes this recognition especially meaningful is that it reflects feedback from customers across our Paychex Flex, Paycor, and SurePayroll HCM platforms, who view Paychex as a trusted partner in helping their organizations grow and succeed,” said John Gibson, Paychex president and CEO. “By combining innovative technology, AI-powered insights, and dedicated human expertise, we help businesses navigate workforce challenges with confidence every day. This recognition reinforces our commitment to delivering the solutions and support our customers need to thrive.”

Helping Businesses Grow, Scale, and Thrive
Every company on the Inc. Power Partner award list received recognition from clients for being instrumental in helping organizational leadership navigate the dynamic world of running a business. These B2B partners support entrepreneurs across various facets of the business, allowing founders to focus on their core missions.

For more than 50 years, Paychex has been on a mission to help businesses succeed. Recent innovations like WISE (Workforce Intelligence Strengthened by Expertise), the company’s AI-powered intelligence engine, expand on this mission by transforming workforce data into actionable insights that help employers save time, improve productivity, and focus on growing their business.

A Proven Track Record of Recognition
Earlier this year, Paychex ranked on TIME’s America’s Top WorkTech Companies list, WISE was named a Top HR Product of the Year by HR Executive, and for the 18th time Paychex was recognized as one of the World’s Most Ethical Companies by Ethisphere.

To learn more about Paychex’s awards and honors, visit the awards page.

About Paychex
Paychex, Inc. (Nasdaq: PAYX) provides a comprehensive suite of expert-enabled technology and advisory solutions that help businesses manage HR, payroll, and benefits. Serving approximately 840,000 clients and paying 1 in 11 U.S. private sector workers, Paychex combines scale, trusted expertise, and innovation to help businesses succeed. Built on more than 50 years of workforce experience and one of the industry’s largest proprietary HR datasets, Paychex’s WISE agentic AI engine embeds intelligence directly into workflows to improve productivity, enhance decision-making, and deliver better outcomes. Learn more at paychex.com.   

Media Contact
Chelsea Wernick
Public Relations Program Manager
Paychex, Inc.
(585) 216-2974
[email protected]

Exelon reports earnings before the open on Oct. 30, and buried inside the call is a transmission pipeline question that could shift how Wall Street prices this utility for years to come.

Exelon (NASDAQ:EXC | EXC Price Prediction) reports third-quarter results before the open on Friday, Oct. 30. Shares trade at $44.42, about 12.6% below $50. I think data center demand is the driver that could close that gap.

Steady Guidance After a Stormy Summer
Last quarter, Exelon posted adjusted operating earnings of $0.43 per share and confirmed full-year guidance of $2.81 to $2.91. Management aims to land “at the midpoint or better.” Jeanne Jones said the third quarter should represent about 27% of that midpoint.

Storms, weather, and a PECO employee strike in early July shaped that outlook. ComEd alone faced 16 major weather events. Exelon also withdrew its PECO rate case without cutting planned capital.

The stock rose 9.17% over the past month and 4.74% year to date, but remains down 3.24% over the past year. Analysts lowered their third-quarter EPS average from $0.8746 90 days ago to $0.7951.

Wall Street Expects a Lighter Third Quarter

Metric
Consensus
Year-Ago Actual
YoY Change

Q3 2026 EPS
$0.7951
$0.86
-7.5%

Q3 2026 Revenue
$6.82B
$6.705B
+1.7%

FY 2026 EPS
$2.8567
$2.77
+3.1%

FY 2026 Revenue
$25.5B
$24.26B
+5.1%

Gigawatts Must Turn Into Signed Contracts
Transmission is the hidden driver. Exelon cut its data center pipeline to 36 gigawatts from 43 gigawatts after a stricter review, yet kept its $41 billion capital plan through 2029 unchanged. 4 gigawatts carry signed transmission security agreements supported by $1 billion of collateral. The focus turns to how much of the remaining 25 gigawatts under review changes into secured commitments.

Management also sees a $12 billion to $17 billion transmission opportunity beyond the plan. Two MISO Tranche 2.1 bids with Invenergy should get answers in the fourth quarter, and a 500-megawatt New Jersey battery project adds about $1 billion not yet in the plan.

PJM’s strain supports the case. Capacity prices cleared at the $330 per megawatt-day cap for a third straight auction, and PJM’s simulation showed ComEd clearing near $777 without it. Regulatory timing is another factor to watch: an order on ComEd’s $15.3 billion grid plan is expected by December 15, while BGE’s $156.1 million request waits a January 2027 decision.

Funding risk looks contained. Exelon completed about 86% of its 2026 debt financing and priced all 2026 equity needs.

Why Transmission Could Re-Rate This Utility
Exelon beat EPS estimates in every quarter from Q2 2024 through Q4 2025, and a softer third quarter already sits in consensus. The path toward $50 runs through rate base. If management turns more of the pipeline into signed, collateral-backed load and holds growth near the top of its 5% to 7% range, I think investors will start valuing Exelon as a grid growth story.

Contact [email protected] for any questions or corrections.

Americká společnost Anthropic dnes podala žádost o vstup na burzu. Firma je jedním z předních hráčů v oblasti umělé inteligence (AI) a podle agentury AP může jít o největší primární veřejnou nabídku akcií (IPO) v historii. Anthropic se zároveň přiblížil k tomu, aby se stal první firmou zaměřenou především na vývoj nejpokročilejších modelů AI, jejíž akcie se začnou veřejně obchodovat, uvedla agentura Bloomberg.

Společnost, která stojí za chatbotem Claude, plánuje zahájit obchodování na trhu Nasdaq Global Select Market pod burzovním symbolem ANT, vyplývá z dokumentu, který firma předložila americké Komisi pro cenné papíry a burzy (SEC). Důvěrnou žádost o vstup na burzu Anthropic podal už v červnu.

Hlavními koordinátory primární veřejné nabídky akcií společnosti Anthropic jsou podle dokumentu investiční banky Goldman Sachs Group a Morgan Stanley.

Z dokumentu vyplývá, že akcie v rámci IPO nabízejí jak společnost Anthropic, tak někteří její stávající akcionáři. Počet nabízených akcií bude zveřejněn v pozdějším dokumentu.

Anthropic v dokumentu uvádí, že v prvním letošním pololetí vykázal čistou ztrátu 80,7 miliardy dolarů (1,76 bilionu Kč) při tržbách 16,3 miliardy dolarů. Ve stejném období loňského roku přitom čistá ztráta činila 13 miliard dolarů a tržby dosáhly 1,2 miliardy USD.

Společnost se dosud zaměřovala především na firemní zákazníky. Její míra udržení čistých výnosů, která měří schopnost udržet si stávající zákazníky a postupně výnosy od těchto zákazníků zvyšovat, dosahuje podle dokumentu 900 procent.

Anthropic uvedl, že ve třetím čtvrtletí letošního roku pocházelo 79 procent jeho tržeb od zákazníků mimo pětici největších odběratelů.

Firma chce využít značné finanční kapacity veřejných kapitálových trhů, aby si udržela náskok před konkurenty. Podniky vyvíjející umělou inteligenci totiž vynakládají stovky miliard dolarů na další zdokonalování takzvaných hraničních modelů AI, tedy nejpokročilejších systémů umělé inteligence.

Anthropic by podle dřívějších informací agentury Bloomberg mohl začít oficiálně propagovat svou primární veřejnou nabídku akcií už v týdnu od 9. listopadu. Firma podle lidí obeznámených se situací očekává, že objemem nabídky vyrovná rekordní IPO společnosti SpaceX, případně jej překoná.

Anthropic i jeho konkurent OpenAI zároveň čelí rostoucí veřejné kritice v souvislosti s bezpečností umělé inteligence. Důvodem je série mediálně sledovaných hackerských incidentů, do kterých se zapojili autonomní agenti jednající bez oprávnění. Tyto události zvyšují obavy z možného dopadu na vstup firmy Anthropic na burzu.

On October 26, 2026, we conducted a DCF analysis for Arista Networks Inc (ANET), a company that has seen a year-to-date increase of 31.6% despite recent price d

Dominion just posted six straight earnings beats while its data center pipeline swells past 53 gigawatts, but Virginia regulators are threatening a freeze that could gut the base-rate growth powering the whole story.

Dominion Energy (NYSE:D | D Price Prediction) is expected to report third-quarter results before the market opens on Friday, October 30. Record data center demand continues raising earnings. At the same time, Virginia officials want a six-year base-rate freeze as the price of the NextEra Energy (NYSE:NEE) merger.

Six Straight Beats Run Into a Political Wall Last quarter, Dominion posted operating EPS of $0.79 against a $0.68 consensus. That made six beats in a row. Revenue rose 17.6% YoY to $4.48B, and Dominion Energy Virginia’s operating earnings climbed to $670M from $549M on Biennial Review effects and rider equity returns. GAAP results looked worse. Nonregulated impairments of $626M cut net income to $340M.

Management reaffirmed 2026 operating EPS guidance of $3.45 to $3.69. Since then, the politics around the deal with NextEra have hardened. Governor Abigail Spanberger and State Corporation Commission staff oppose the merger. They are demanding a six-year base-rate freeze and tripled customer credits. Even so, shares have gained 14.73% year to date, to $65.20.

Consensus Calls for Double-Digit EPS Growth Metric Consensus Prior Year YoY Growth Q3 2026 EPS $1.1933 $1.06 12.6% Q3 2026 Revenue $4.80B $4.53B 6.1% FY 2026 EPS $3.5857 $3.42 4.8% FY 2026 Revenue $18.16B $16.5B 10.0% The Q3 EPS estimate has slipped from $1.2059 60 days ago. Analysts made two downward revisions in the past month.

Freeze Talk and the 53 GW Pipeline Will Set the Tone Mostly, I’ll be watching how management responds to the freeze demand before Virginia’s formal hearings begin November 17. Rider returns and base-rate increases drove this year’s Virginia gains, and a six-year freeze would cap the base-rate side. In July, Robert Blue pushed back: “We don’t think it makes sense to change the rules in the middle of the game.”

Demand remains the strongest card Dominion holds. The utility has over 53 gigawatts of data center capacity in various stages of contracting, with about 12 gigawatts under electric service agreements. You should track whether that signed figure continues rising, because signed contracts are what turn into rate base.

Offshore wind is the third test. The Coastal Virginia Offshore Wind project was 81% complete, with costs revised to $11.65 billion and final turbine installation pushed back 6 months. Any further decline would matter.

Finally, watch the new resource plan. It proposes nearly 9 GW of new gas plants and only 3.5 GW of battery storage, against Virginia’s 16 GW storage mandate. Dominion has also sued Prince William County after local supervisors blocked a substation overhaul.

A Freeze Would Rewrite the Growth Math Dominion’s target of 5% to 7% annual EPS growth through 2030 depends on a $64.7B capital plan making regulated returns. The demand is clearly there. What’s uncertain is how much of that spending regulators will let Dominion recover. If management shows a merger path that avoids punishing freeze terms, the rally has support. If those terms stick, the company’s stated lean toward the upper half of its range for 2028 to 2030 becomes much harder to defend.

Contact [email protected] for any questions or corrections.

Key Takeaways HMC gained 8.1% after its Zacks Rank upgrade, while BILL returned 6.3% in the same period.CACI surged 31.9% over 12 weeks, while Ulta Beauty climbed 30.7%, outpacing the S&P 500.ACN jumped 79.7% over 12 weeks, while CHKP gained 26.2% in the same period. The three benchmark Wall Street indexes delivered mixed performance for the week ended October 23. The tech-focused Nasdaq Composite fell 0.7%, while the S&P 500 declined 0.5%. The Dow Jones Industrial Average, however, added 0.4% to mark a third straight week of gains.

Technology shares faced heavy selling as investors questioned whether massive artificial intelligence investments would generate sufficient returns, with concerns about financing costs adding to pressure. Renewed Middle East tensions pushed oil prices higher, reviving inflation fears and uncertainty over interest rates. Defensive sectors and value-oriented stocks helped limit broader market losses.

Investor sentiment remained cautious despite generally supportive corporate earnings. With major technology companies preparing to report results and the Federal Reserve’s policy meeting approaching, investors were closely monitoring capital-spending plans, profit outlooks and interest-rate signals.

Regardless of market conditions, we, here at Zacks, provide investors with unbiased guidance on how to beat the market. 

As usual, Zacks Research guided investors over the past three months with its time-tested methodologies. Given the prevailing market uncertainty, you may want to look at our feats to prepare better for your next action.

Here are some of our key achievements:

Honda Motor and BILL Surge Following Zacks Rank UpgradeShares of Honda Motor Co., Ltd. (HMC - Free Report) have gained 8.1% (versus the S&P 500’s 2.2% decrease) since it was upgraded to a Zacks Rank #1 (Strong Buy) on August 17.

Another stock, BILL Holdings, Inc. (BILL - Free Report) , which was also upgraded to a Rank #1 on August 26, has returned 6.3% since then.

A portfolio of Zacks # 1 Rank (Strong Buy) stocks has outperformed the S&P 500 index by 3.9 percentage points this year. Through October 5th this year, the Zacks # 1 Rank portfolio returned +16.9%, which compares to a +13% gain for the S&P 500 index and an +8.1% gain for the equal-weight version of the index in the same time period.

Since its inception in 1988, this portfolio of Zacks # 1 Rank stocks has outperformed the market by 12.2 percentage points. The average annual return for this portfolio of Zacks # 1 Rank stocks since inception in 1988 was +23.8% through October 5th, which compares to a +11.6% gain for the S&P 500 index and a +11.2% gain for the equal-weight version of the index.

You can see the complete list of today’s Zacks Rank #1 stocks here >>>

Check Honda Motor’s historical EPS and Sales here>>>

Check BILL’s historical EPS and Sales here>>>

Zacks Recommendation Upgrades Telos and NIQ GlobalShares of Telos Corporation (TLS - Free Report) and NIQ Global Intelligence plc (NIQ - Free Report) have surged 9.9% and 9.3% (versus the S&P 500’s 1.2% fall), respectively, since their Zacks Recommendation was upgraded to Outperform on August 5.

While the Zacks Rank is our short-term rating system that is most effective over the one- to three-month holding horizon, the Zacks Recommendation aims to predict performance over the next 6 to 12 months. However, just like the Zacks Rank, the foundation for the Zacks Recommendation is trends in earnings estimate revisions.

The Zacks Recommendation classifies stocks into three groups — Outperform, Neutral and Underperform. While these recommendations are determined quantitatively, our analysts have the flexibility to override them for the 1100+ stocks they closely follow based on their better judgment of factors such as valuation, industry conditions and management effectiveness than the quantitative model.

To access our research reports with Zacks Recommendations for the 1100+ stocks we cover, click here>>>

Zacks Focus List Stocks CACI & Ulta Beauty Shoot UpShares of CACI International Inc. (CACI - Free Report) , which belongs to the Zacks Focus List, have soared 31.9% over the past 12 weeks. The stock was added to the Focus List on December 2, 2015. Another Focus-List holding, Ulta Beauty, Inc. (ULTA - Free Report) , which was added to the list on March 25, 2020, has returned 30.7% over the past 12 weeks. The S&P 500 has advanced 2.9% over this period. 

The 50-stock Focus List portfolio returned +13.78% in the year-to-date period (through September 30th, 2026) vs. +12.75% for the S&P 500 index and +10.03% for the equal-weight version of the index.

The portfolio returned +22.1% in 2025 vs. +17.9% for the S&P 500 index and +11.4% for the equal-weight version of the index.

The Zacks Focus List portfolio returned +18.41% in 2024 vs. +25.04% for the S&P 500 index and +13% for the equal-weight S&P 500 index. The portfolio had returned +29.54% in 2023 vs. +26.28% for the S&P 500 index and +13.61% for the equal-weight S&P 500 index. In 2022, the portfolio returned -15.2% vs. the S&P 500 index’s -17.96%.

Through September 30th, 2026, the portfolio’s rolling returns on a one-year, three-year, five-year, ten-year, and since 2004 have been +17.49% (vs. +15.74% for the S&P 500 index), +24.4% (vs. +22.9%), +13.5% (vs. +13.8%), +16.4% (vs. +15.3%) and +12.4% vs. (+10.9%), respectively.

Unlock all of our powerful research, tools and analysis, including the Focus List, Zacks #1 Rank List, Equity Research Reports, Zacks Earnings ESP Filter, Premium Screener and more, as part of Zacks Premium. Gain full access now >>

Zacks ECAP Stocks Accenture & Check Point Gain SignificantlyAccenture plc (ACN - Free Report) , a component of our Earnings Certain Admiral Portfolio (ECAP), has jumped 79.7% over the past 12 weeks. Check Point Software Technologies Ltd. (CHKP - Free Report) followed Accenture with 26.2% returns.

The Zacks Earnings Certain Admiral Portfolio (ECAP), which consists of 30 concentrated, ultra-defensive, long-term Buy-and-Hold stocks, returned -4.7% in 2026 (through September 30th, 2026) vs. +12.75% for the S&P 500 index.

For 2025, the portfolio returned -1.67% vs. a +17.9% gain for the S&P 500 index. For the year 2024, the portfolio returned +16.26% vs. +24.89% for the S&P 500 index (SPY ETF). In 2023, the portfolio returned +12.17% vs. +26.28% for the S&P 500 index. The portfolio returned -4.7% in 2022 vs. the S&P 500 index’s -17.96%.

With little to no turnover and annual rebalance periodicity, ECAP seeks to minimize capital loss by holding shares of companies whose earnings streams exhibit a proven 20+ year track record of surviving recessionary periods with minimal impact on aggregate earnings growth relative to the overall S&P 500.

The ECAP and many other model portfolios are available as part of Zacks Advisor Tools, a cloud-based solution to access Zacks award-winning stock, mutual fund and ETF research. Click here to schedule a demo.

Zacks ECDP Stocks Automatic Data Processing & Procter & Gamble Outperform PeersAutomatic Data Processing, Inc. (ADP - Free Report) , which is part of our Earnings Certain Dividend Portfolio (ECDP), has returned 25.2% over the past 12 weeks. Another ECDP stock,The Procter & Gamble Company (PG - Free Report) , has climbed 9.6% over the same time frame. Of course, the inclination of investors toward quality dividend stocks to secure an income stream amid heightened market volatility contributed to this performance.

Check Automatic Data Processing’ dividend history here>>>  

Check Procter & Gamble’s dividend history here>>>

With an extremely low beta and a history of minimum earnings variability over the last 20+ years, this 25-stock portfolio helps significantly mitigate risk.

The Zacks Earnings Certain Dividend Portfolio (ECDP) returned +2.01% in the year-to-date period (through September 30th) vs. +12.75% for the S&P 500 index.

The portfolio returned -0.6% in 2025 vs. a +6.8% gain for the Dividend Aristocrats ETF. For the full year 2024, the portfolio returned +6.95% vs. +24.89% for the S&P 500 index and +6.72% for NOBL. The portfolio returned -0.9% in 2023 vs. +26.28% for the S&P 500 index and +8.11% for NOBL. The portfolio returned -2.3% in 2022 vs. -17.96% for the S&P 500 index and -8.34% for NOBL.

Click here to access this portfolio on Zacks Advisor Tools.

Zacks Top 10 Stock Monolithic Power Delivers Solid ReturnsMonolithic Power Systems, Inc. (MPWR - Free Report) , from the Zacks Top 10 Stocks for 2025, has jumped 21.8% since January 5, 2026, compared with the S&P 500 Index’s 11.2% increase.

The Top 10 portfolio returned +8.34% in the year-to-date 2026 period (through September 30th) vs. +12.75% for the S&P 500 index and +10.03% for the equal-weight version of the index.

The Top 10 portfolio returned +22.6% in 2025 vs. +17.9% for the S&P 500 index and +11.4% for the equal-weight version of the index.

The Top 10 portfolio returned +62.98% in 2024, vs. +25.04% for the S&P 500 index and +13% for the equal-weight version of the index. The portfolio had returned +25.15% in 2023 vs. +26.28% for the S&P 500 index.

Through the end of September 2026, the Top 10 portfolio has produced a cumulative return of +2,706.5% since 2012 vs. +645.9% for the S&P 500 index and +453.8% for the equal-weight version of the index. The portfolio has produced an average annual return of +25.1% in the period 2012 through September 30th, 2026, vs. +13.5% for the S&P 500 index and +10.8% for the equal-weight version of the index.

New York, New York--(Newsfile Corp. - October 26, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Azenta, Inc. (NASDAQ: AZTA) resulting from allegations that Azenta may have issued materially misleading business information to the investing public.

SO WHAT: If you purchased Azenta securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.

WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/cases/azenta-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

WHAT IS THIS ABOUT: On August 24, 2026, Azenta filed with the SEC a current report on Form 8-K which stated that on "August 22, 2026, John P. Marotta resigned as President and Chief Executive Officer of Azenta, Inc. (the "Company") and as a member of the Company's Board of Directors (the "Board"), effective as of August 22, 2026 (the "Effective Date")."

On this news, Azenta's stock fell 12% on August 24, 2026.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/320811

Source: The Rosen Law Firm PA

Ready to Announce with Confidence?
Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us

 | Source:

Certara

RADNOR, Pa., Oct. 26, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that it will release financial results for the third quarter of 2026 before market open on Thursday, November 5th, 2026. Company management will host a conference call to discuss financial results at 8:30AM ET.

To listen by phone, investors may dial 800-715-9871 (646-307-1963 for international callers) and enter access code 2208277. The live webcast will be available through the Certara Earnings Webcast link and the Investor Relations section of the Company’s website at ir.certara.com, where a replay will be archived.

About Certara

Certara transforms drug discovery and development for good, helping scientists and clinical teams generate regulatory-grade evidence faster. Its solutions combine biosimulation, clinical intelligence, and regulatory science, and are embedded in the workflows of drug developers worldwide. Certara clients include more than 2,600 biopharmaceutical companies, academic institutions, and global regulatory agencies. Learn more at certara.com.

Investor Relations and Media Contact: 

Jeff Warren and Jay Liu
[email protected]

-

Connecting Mission-Critical Sensing, Detection and Monitoring Technology with Edge Controls

Parameter Will Become Part of Distech Controls Within Acuity Intelligent Spaces upon ClosingCombining Parameter’s Sensing, Detection and Monitoring Technology With Distech’s Edge Controls Will Help Customers Detect Problems and Resolve Issues Earlier FORT COLLINS, Colo.--(BUSINESS WIRE)--Parameter Technologies (“Parameter”) today announced that it has entered into a definitive agreement to be acquired by Acuity Inc. (NYSE: AYI) (“Acuity”) for a purchase price of $675 million. Upon closing, Parameter will become part of Distech Controls within the Acuity Intelligent Spaces business segment.

Distech is a leader in building controls, combining open protocols and tools with edge controls, cloud intelligence and an open go-to-market model. Parameter will benefit from access to this technology and Acuity’s scale, while building on our existing work with Distech across shared system integrator, distributor and cooling equipment OEM relationships. Together, Distech and Parameter can connect our sensing, detection and monitoring technology with Distech’s controls to help customers to be able to detect problems and resolve issues earlier and better protect mission-critical operations.

“We have built our business around technology that customers trust to protect critical equipment,” said Michael Blazes, Chief Executive Officer of Parameter. “Joining Acuity allows us to build on that success. Together, we can bring our technology to more applications, help customers identify issues earlier and take action to better protect their operations.”

“Parameter has built a high-performing business that is highly complementary to Distech’s portfolio,” said Peter Han, President of Acuity Intelligent Spaces. “By combining Parameter’s sensing, detection and monitoring technology with Distech’s edge controls, we expand our capabilities in data centers and deepen relationships with channel partners. This builds on Distech’s proven ability to solve customer problems and scale adjacent technologies that support durable growth for Acuity Intelligent Spaces.”

Transaction Close

The transaction is expected to close in late 2026, subject to customary closing conditions, including, among others, the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended. Until the transaction closes, Parameter and Acuity will continue to operate independently, and Parameter will remain focused on serving its customers and partners.

Lincoln International is serving as lead financial advisor to Parameter and Paul Hastings is providing external legal counsel.

About Acuity

Acuity Inc. (NYSE: AYI) is a market-leading industrial technology company. We use technology to solve problems in spaces, light and more things to come. Through our two business segments, Acuity Brands Lighting (ABL) and Acuity Intelligent Spaces (AIS), we design, manufacture, and bring to market products and services that make a valuable difference in people’s lives.

We achieve growth through the development of innovative new products and services, including lighting, lighting controls, building management solutions, and an audio, video and control platform. We focus on customer outcomes and drive growth and productivity to increase market share and deliver superior returns. We look to aggressively deploy capital to grow the business and to enter attractive new verticals.

Acuity Inc. is based in Atlanta, Georgia, with operations across North America, Europe and Asia. The Company is powered by approximately 13,000 dedicated and talented associates. Visit us at www.acuityinc.com.

About Parameter Technologies

Parameter Technologies develops monitoring and detection solutions for data centers, utilities and critical infrastructure. Through its RLE Technologies and CellWatch brands, Parameter provides leak detection, environmental monitoring and battery monitoring solutions that help facility operators protect performance and minimize costly downtime. Parameter is headquartered in Fort Collins, Colorado, with engineering and service operations in Raleigh, North Carolina, and sales and service capabilities in Milton Keynes, United Kingdom.

More News From Parameter Technologies

Back to Newsroom

Whirlpool Corporation (NYSE:WHR) will release its third-quarter earnings report after the closing bell on Monday, Oct. 26.

Key Takeaways Raymond James' Q4 earnings are projected to rise 5.5%, with revenues expected to grow 12.3% year over year.RJF's trading revenues are poised to gain from heightened market volatility and increased client activity.RJF's investment banking fees are expected to fall 4.9%, while NII is projected to rise 2.9%.
Raymond James (RJF - Free Report) is set to announce fourth-quarter and full-year fiscal 2026 (ended Sept. 30) results on Oct. 28, after market close. The company’s quarterly earnings and revenues are expected to have risen on a year-over-year basis.

In the last reported quarter, RJF’s earnings surpassed the Zacks Consensus Estimate. Results benefited primarily from an increase in revenues to record levels and robust growth in the assets under administration balance. However, higher expenses were the undermining factor.

Raymond James has an impressive earnings surprise history. Its earnings outpaced the Zacks Consensus Estimate in each of the trailing four quarters, with the average beat being 6.67%.

The Zacks Consensus Estimate for the company’s fiscal fourth-quarter earnings is pegged at $3.28, unchanged over the past week. The figure indicates an increase of 5.5% from the year-ago quarter.

The consensus estimate for sales of $4.19 billion suggests 12.3% year-over-year growth.

Management expects fiscal third-quarter asset management and related administrative fees to grow 11% sequentially, driven by higher Private Client Group assets and fee-based accounts balance at quarter end.

Factors to Influence Raymond James’ Q4 EarningsInvestment Banking (IB) Fees: After an impressive performance in the last few quarters, global deal-making activity moderated in the September quarter, weighed down by elevated interest rates, persistent inflation and geopolitical uncertainties that complicated valuations and deal negotiations. Still, strategic buyers continued to pursue acquisitions to strengthen scale, operational resilience and supply-chain security amid a challenging business environment. So, overall global mergers and acquisitions (M&As) volume and value were muted as only a handful of big transactions dominated the space. This is expected to have hurt RJF’s advisory fees in the quarter.

IPO activity remained robust in the to-be-reported quarter, with proceeds climbing to a five-year high, despite a year-over-year decline in the number of deals. Meanwhile, global equity and debt issuance activity lost momentum as geopolitical uncertainties, persistent inflation and fluctuating energy prices dampened investor risk appetite. So, RJF’s underwriting fees are expected to have declined on a year-over-year basis.

The Zacks Consensus Estimate for the company’s total IB fees for the fiscal fourth quarter is pegged at $300.5 million, indicating a 4.9% decrease on a year-over-year basis.

Trading Revenues: The performance of RJF’s trading business is expected to have been strong in the to-be-reported quarter, supported by increased client activity and market volatility. Trading conditions were shaped by evolving expectations surrounding artificial intelligence, ongoing geopolitical tensions, persistent inflationary pressures and a more hawkish Federal Reserve. These factors contributed to heightened volatility across equities and other asset classes, including commodities, fixed income and foreign exchange.

Net Interest Income (NII): In the to-be-reported quarter, the Fed raised interest rates by 25 basis points to 3.75-4.00% for the first time in more than three years because of persistently high inflation. However, this is less likely to have affected Raymond James’ NII numbers much in the quarter.

The lending scenario is likely to have normalized in the September-end quarter, which, along with stabilizing funding/deposit costs, is expected to have offered much-needed support to RJF’s NII.

The Zacks Consensus Estimate for NII is pegged at $567.1 million, indicating a year-over-year rise of 2.9%.

Based on static interest rates and assuming unchanged quarter-end balances and net of the fiscal fourth-quarter fee billing collection of $2.1 billion, the company expects the aggregate of NII and Raymond James Bank Deposit Program (RJBDP) third-party fees in the fourth fiscal quarter to be flat sequentially.

Expenses: Raymond James consistently hires advisors and invests in franchises. Thus, overall expenses are expected to have increased in the to-be-reported quarter. Due to a highly competitive environment and inflationary pressure, expenses are likely to have risen.

For fiscal 2026, management expects non-compensation expenses, excluding the bank loan loss provision for credit losses, unexpected legal and regulatory items, and non-GAAP adjustments to be $2.3 billion, representing 8% year-over-year growth.

What the Zacks Model Unveils for Raymond JamesAccording to our proven model, the chances of RJF beating the Zacks Consensus Estimate for earnings this time are low. This is because it does not have the right combination of two key ingredients — a positive Earnings ESP and a Zacks Rank #3 (Hold) or better.

You can uncover the best stocks to buy or sell before they are reported with our Earnings ESP Filter.

Earnings ESP: The Earnings ESP for Raymond James is -0.82%.

Zacks Rank: The company currently has a Zacks Rank #3.

Finance Stocks Worth ConsideringHere are a couple of finance stocks that you may want to consider, as our model shows that these have the right combination of elements to post an earnings beat this time around.

Invesco (IVZ - Free Report) is scheduled to announce quarterly numbers on Oct. 27. The company has an Earnings ESP of +0.10% and carries a Zacks Rank #3 at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Quarterly earnings estimates for Invesco have been revised marginally upward to 75 cents over the past week.

The Earnings ESP for Prosperity Bancshares (PB - Free Report) is +0.04%, and it carries a Zacks Rank #3 at present. The company is slated to report third-quarter 2026 results on Oct. 28.

Over the past seven days, the Zacks Consensus Estimate for Prosperity Bancshares’ quarterly earnings has been unchanged at $1.63 per share.

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Range Resources Corporation (NYSE: RRC) to EQT Corporation for 0.987 shares of EQT common stock for each share of Range common stock. Upon completion of the proposed transaction, Range shareholders are expected to own approximately 27% of the combined company. Halper Sadeh encourages Range shareholders to click here to learn more about their rights and options or contact Daniel Sadeh or Zachar.

38.02K Followers

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

SummaryBaron Real Estate Income Fund decreased 7.58% (Institutional Shares) in the third quarter, underperforming the MSCI US REIT Index, which decreased 6.33%.Welltower is a leading owner and operator of senior housing communities across the U.S., Canada, and the U.K., and is the largest health care REIT by market capitalization.We initiated a position in AAON, Inc., following a disappointing second quarter earnings result.Despite the quarterly pullback, The Macerich Company's management continues to execute well, tracking ahead of targets on leasing, occupancy, space buildouts, select dispositions, and debt paydown. courtneyk/iStock via Getty Images

The following segment was excerpted from Baron Real Estate Income Fund Q3 2026 Shareholder Letter.

Top Contributors and Detractors Top contributors to performance for the quarter

Quarter End Market Cap($B) Contribution to Return(%) Welltower

705 Followers

Arm's stock has shed half its value while its three core revenue engines keep accelerating, leaving investors to decide whether a brutal sell-off signals a buying opportunity or a warning sign about what comes next.

CINCINNATI & BRENTWOOD, Tenn.--(BUSINESS WIRE)--HealthSpan Partners, a contractual affiliate and supporting organization of U.S.-based Bon Secours Mercy Health (“BSMH”), and Surgery Partners, Inc. (NASDAQ:SGRY), a leading short-stay surgical facility owner and operator, today announced a definitive agreement under which HealthSpan Partners will acquire Surgery Partners in an all-cash transaction valued at an enterprise value of approximately $5.7 billion. Under the terms of the agreement, Surge.

ABU DHABI, United Arab Emirates & NEW YORK--(BUSINESS WIRE)--Mubadala Capital, the alternative asset management arm of Mubadala Investment Company, today announced a strategic investment from Apollo (NYSE: APO) to support its next phase of growth. Building on their existing relationship, Apollo will take a minority equity stake in Mubadala Capital and commit capital across its various investment strategies, working alongside Mubadala Capital as it continues scaling a world-class alternative ass.

MIDLAND, Texas--(BUSINESS WIRE)---- $ASTS #AST--AST SpaceMobile, Inc. (“AST SpaceMobile”) (NASDAQ: ASTS), the company building the first and only space-based cellular broadband network accessible directly by everyday smartphones, designed for both commercial and government applications, today announced significant progress toward bringing space-based cellular broadband to Brazil, Latin America's largest economy. AST SpaceMobile has secured S-band spectrum authorization from Brazil's National Telecommunication.

New York, New York--(Newsfile Corp. - October 26, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Hims & Hers Health, Inc. (NYSE: HIMS) between August 4, 2025 and July 29, 2026, both dates inclusive (the "Class Period"), of the important November 2, 2026 lead plaintiff deadline. SO WHAT: If you purchased Hims securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

LOS ANGELES, Oct. 26, 2026 (GLOBE NEWSWIRE) -- Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Hims & Hers Health, Inc. (“Hims & Hers” or “the Company”) (NYSE: HIMS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Shareholders who purchased shares of HIMS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery.

CLASS PERIOD: August 4, 2025 to July 29, 2026

DEADLINE: November 2, 2026

If you are a shareholder who suffered a loss, click here to participate.

CASE DETAILS: According to the Complaint, the Company made false and misleading statements to the market. Hims & Hers provided customer health data to third-party advertising platforms. The Company’s treatment practices were likely to result in heightened regulatory scrutiny. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Hims & Hers, investors suffered damages.

We also encourage you to contact Brian Schall or David Schwartz of Schall, Brown & Schwartz LLP, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at [email protected].

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

Join the case to recover your losses

WHY SBS? Schall, Brown & Schwartz LLP represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation. Bringing together the extensive experience and diverse skillsets of founding partners Brian Schall, Andrew Brown, and David Schwartz, SBS is dedicated to aggressively advocating for every investor.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.        

CONTACT:

Schall, Brown & Schwartz LLP
Brian Schall, Esq.,
Andrew Brown, Esq.,
David Schwartz, Esq.,
www.schallfirm.com
Office: 310-301-3335
[email protected]

SOURCE:

 Schall, Brown & Schwartz LLP

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM) today announced that its xR assay has received certification under the European Union's In Vitro Diagnostic Regulation (IVDR) as a Class C in vitro diagnostic device. The certification covers Tempus' quality management system for "next-generation sequencing devices for cancer genomic profiling to support clinical management." xR detects gene rearrangements and specific splice variants in solid tumor tissue to support clinical management. A.

Atlas Energy Solutions (NYSE: AESI - Get Free Report) will likely be announcing its Q3 2026 results after the market closes on Monday, November 2nd. Analysts expect Atlas Energy Solutions to post earnings of ($0.2387) per share and revenue of $264.71 million for the quarter. Investors can check the company's upcoming Q3 2026 earnings report for